Business · 27/09/2012Updated: 10/17/2026 · 1 min read
FDA Clears ENDURON (methyclothiazide) Tablets and Six Other Drug Products for Sale
Summary
The US Food and Drug Administration (FDA) has ruled that the seven listed drug products, including ENDURON (methyclothiazide) tablets, were not withdrawn from the market due to safety or effectiveness concerns, allowing the FDA to continue approving new applications for these products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →